Celgene Corporation (CELG)
N/A
  • CONTENT
  • SOURCES
Bristol-Myers Squibb Company Announces Final Results of Exchange Offers for Celgene Corporation Notes
NEW YORK--(BUSINESS WIRE)---- $BMY--Bristol-Myers Squibb Company Announces Final Results of Exchange Offers for Celgene Corporation Notes
Bristol-Myers Closes $74 Billion Celgene Takeover; Shares Gain
Bristol-Myers Squibb BMY shares were indicated higher in pre-market trading after the pharmaceutical group said it has completed its $74 billion acquisition of cancer drug specialist Celgene Corp. CELG….BMY
Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company
Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the recei
CELGENE ERHÄLT DIE ZULASSUNGSEMPFEHLUNG DES CHMP FÜR LENALIDOMID (REVLIMID®) IN KOMBINATION MIT RITUXIMAB ZUR BEHANDLUNG VON ERWACHSENEN PATIENTEN MIT VORBEHANDELTEM FOLLIKULÄREM LYMPHOM
SUMMIT, N.J.--(BUSINESS WIRE)--Wie die Celgene Corporation (NASDAQ:CELG) heute bekannt gab, hat der Ausschuss für Humanarzneimittel (CHMP) der Europäischen Arzneimittelbehörde (EMA) eine Zulassungsempfehlung für Lenalidomid (REVLIMID®) in Kombination mit Rituximab (anti-CD20-Antikörper) (R²) zur Behandlung erwachsener Patienten mit vorbehandeltem follikulärem Lymphom (FL) (Schweregrad 1-3a) veröffentlicht. Für Patienten mit FL wird R2 nach erteilter Zulassung durch die Europäische Kommission (E
Eine der weltgrößten Biotech-Aktien wird schon in wenigen Stunden nicht mehr gehandelt werden. Was ist da los?
Die Aktie von Celgene wird bald sowohl aus dem S&P 500 als auch aus dem Nasdaq 100 fliegen. Warum das so ist und wer die Nachfolger sind. Von Matthias Fischer
ServiceNow Jumps as Stock Is Added to the S&P 500, Replacing Celgene
The cloud computing company will join the S&P 500 index on Thursday….NOW
ServiceNow's stock jumps on cloud company's addition to the S&P 500
Cloud software vendor ServiceNow was added to the S&P 500 on Monday, replacing Celgene, which is being acquired.
Bristol-Myers Expects to Complete Its Deal for Celgene on Wednesday
Bristol-Myers said Friday it had satisfied all regulatory requirements to complete the Celgene deal.
Bristol-Myers Gets FTC Clearance for Celgene Acquisition
Bristol-Myers (BMY) obtains FTC permission for the Celgene acquisition and will divest Otezla to Amgen.
Bristol-Myers Squibb Company Announces It Expects No Further Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes
NEW YORK--(BUSINESS WIRE)---- $BMY--Bristol-Myers Squibb Company Announces It Expects No Further Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes
Celgene (CELG): what causing the price drop?
Celgene is down another 5% today. What's driving the stock price 'free fall'? What's the CELG stock price forecast?
Top 6 Biotech Stocks For Traders
If you’re up for some speculative biotech trades, we are presenting the top 6 among our freshest picks of biotech stocks for the coming 12 months.
Follow Us